XML 70 R56.htm IDEA: XBRL DOCUMENT v3.24.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 01, 2024
Dec. 20, 2023
Aug. 01, 2023
Aug. 01, 2023
Jul. 07, 2019
Aug. 27, 2018
Jul. 31, 2022
Apr. 30, 2022
May 31, 2020
Apr. 30, 2020
Oct. 31, 2019
Dec. 31, 2023
Dec. 31, 2022
Aug. 31, 2023
Apr. 04, 2022
Loss Contingencies [Line Items]                              
Payment of cash                       $ 9,942,750 $ 2,516,164    
Cash consideration     $ 16,792,037                        
Payment in cash                       $ 3,089,645 $ 11,125,872    
Options to acquire shares               144,191            
Weighted exercise price               $ 10.71              
Warrants to purchase shares               4,424              
Exercise price               $ 7.32              
Expiration date               Apr. 22, 2031              
Payments receive     $ 893,000                        
cash                           $ 693,000  
Cash consideration             $ 10,000,000.0                
Number of shares             486,145                
Cash Closing Consideration [Member]                              
Loss Contingencies [Line Items]                              
Purchase price       $ 15,250,000                      
Common Stock [Member]                              
Loss Contingencies [Line Items]                              
Issuance of shares                       73,809 457,424    
Payment in cash                       $ 74 $ 457    
Warrants to purchase shares               12,301              
Exercise price               $ 12.05              
Expiration date               Aug. 10, 2030              
Number of shares isssued                       26,143      
Precision Healing Inc [Member]                              
Loss Contingencies [Line Items]                              
Cash consideration               $ 125,966              
Payments receive               $ 10,000,000.0              
Precision Healing [Member]                              
Loss Contingencies [Line Items]                              
Payments receive                   $ 10,000,000.0          
Rochal [Member]                              
Loss Contingencies [Line Items]                              
Payment of cash                 $ 500,000            
Accredited Investors [Member]                              
Loss Contingencies [Line Items]                              
Issuance of shares               165,738              
Nonaccredited Investors [Member]                              
Loss Contingencies [Line Items]                              
Share price                             $ 30.75
Precision Healing [Member]                              
Loss Contingencies [Line Items]                              
Payment in cash               $ 600,000              
Share price               $ 27.13   $ 27.13          
Cost of Sales [Member]                              
Loss Contingencies [Line Items]                              
Royalty expense                       $ 991,099 1,771,219    
Sub License Agreement [Member]                              
Loss Contingencies [Line Items]                              
License agreement and royalties description           In August 2018, the Company entered an exclusive, world-wide sublicense agreement with CGI Cellerate RX, LLC (“CGI Cellerate RX”) to distribute CellerateRX Surgical and HYCOL products into the surgical and wound care markets. Pursuant to the sublicense agreement, the Company pays royalties of 3-5% of annual collected net sales of CellerateRX Surgical and HYCOL. As amended in January 2021, the term of the sublicense extends through May 2050, with automatic successive year-to-year renewal terms thereafter so long as the Company’s Net Sales (as defined in the sublicense agreement) each year are equal to or in excess of $1,000,000. If the Company’s Net Sales fall below $1,000,000 for any year after the initial expiration date, CGI Cellerate RX will have the right to terminate the sublicense agreement upon written notice.                  
BIAKOS License Agreement [Member]                              
Loss Contingencies [Line Items]                              
Royalty expense                       130,000 120,000    
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member]                              
Loss Contingencies [Line Items]                              
Increase of royalties payable                       10,000      
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage         2.00%                    
Maximum amount of royalty                         $ 120,000    
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage         4.00%                    
Maximum amount of royalty                       150,000      
BIAKOS Agreement [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Payment for additional royalties                       $ 1,000,000      
ABF License Agreement [Member]                              
Loss Contingencies [Line Items]                              
Royalty annual minimum percentage                       10.00%      
ABF License Agreement [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage                     2.00%        
Maximum amount of royalty                       $ 50,000      
ABF License Agreement [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage                     4.00%        
Maximum amount of royalty                       75,000      
Payment for additional royalties                       $ 500,000      
Debrider License Agreement [Member]                              
Loss Contingencies [Line Items]                              
Royalty annual minimum percentage                       10.00%      
Payment of cash                 $ 1,000,000            
Debrider License Agreement [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage                 2.00%            
Maximum amount of royalty                 $ 100,000            
Debrider License Agreement [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Royalty percentage                 4.00%            
Maximum amount of royalty                       $ 150,000      
Payment for additional royalties                       $ 1,000,000      
Purchase Agreement [Member]                              
Loss Contingencies [Line Items]                              
Acquisition consideration transferred             $ 7,600,000                
cash             $ 1,600,000                
Issuance of common stock for purchase of assets             291,686                
Number of shares isssued             94,798                
Purchase price             $ 7,600,000                
Services Agreement [Member]                              
Loss Contingencies [Line Items]                              
Purchase agreement description       As consideration for the Petito Services, the Owner is entitled to receive: (i) a base salary of $12,000 per month during the term of the Petito Services Agreement, (ii) a royalty payment equal to three percent (3%) of the actual collections from net sales of certain products the Owner develops or codevelops that reach commercialization, (iii) a royalty payment equal to five percent (5%) for the first $50.0 million in aggregate collections from net sales of certain future products and a royalty payment of two and one-half percent (2.5%) on aggregate collections from net sales of certain future products on any amounts exceeding $50.0 million but up to $100.0 million, (iv) $500,000 in cash in the event that 510(k) clearance is issued for any future product accepted by the Company and (v) $1.0 million in cash in the event that a U.S. patent is issued for a certain product; provided that with respect to the incentive payments described in (iv) and (v) of the foregoing, the Owner shall not earn more than $2.5 million.                      
License Agreement [Member]                              
Loss Contingencies [Line Items]                              
Royalty expense $ 50,000                            
[custom:OutstandingUnitsPercentage]   10.00%                          
License Agreement [Member] | Subsequent Event [Member]                              
Loss Contingencies [Line Items]                              
Royalty expense $ 100,000                            
License Agreement [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
[custom:RoyaltyExpensePercentage]   1.50%                          
License Agreement [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
[custom:RoyaltyExpensePercentage]   3.00%